The Alliance is proud to share that Cynthia Bens, our Vice President of Public Policy, will present on a panel at the DIA 28th Annual EuroMeeting in Hamburg, Germany:

Frailty as a Baseline Stratification Parameter and Potential Therapeutic Target
April 7, 2016
11:00 AM – 12:30 PM (Central European Standard Time)
Track: Special Populations
Session Number: S1102

Progress made in drug development for and with older people? This session will announce and discuss the brand new EMA Geriatric Working Party frailty definition selected for study baseline characteristics for clinical studies and propose how this will change the research landscape in geriatric studies in Europe and beyond.

Chair: Florian von Raison, Dr Med
Senior Global Program Head and Chairman
Geriatric Medicine Working Party/ EFGCP
Novartis Pharma AG, Switzerland

Presentation(s) & Speaker(s):

The EMA Geriatric Medicines Strategy, Good Pharmacovigilance Practice (GVP) and What Leads Us to Single out Frailty
Susan Morgan
Medical Assessor
Medicines & Healthcare Products Regulatory Agency (MHRA)
United Kingdom

SPRINTT- IMI
Susanna Del Signore, MD
Director and Founder
Bluecompanion
United Kingdom

The Frailty Guideline under Consultation: What Does It Mean in Terms of CT Population and Registries
Antonio Cherubini
Head of Geriatrics
IRCCS-INRCA
Italy

Addressing Areas of Need / Insufficient Research
Cynthia Bens
VP, Public Policy
Alliance for Aging Research
United States

Roundtable Discussion
Francesca Cerreta, PharmD, MPharm, MS
Senior Scientific Officer
European Medicines Agency
European Union, United Kingdom